Literature DB >> 2579126

The immunobiology of T cell responses to Mls-locus-disparate stimulator cells. II. Effects of Mls-locus-disparate stimulator cells on cloned, protein antigen-specific, Ia-restricted T cell lines.

M E Katz, C A Janeway.   

Abstract

Cloned, protein antigen-specific, Ia-restricted T cell lines frequently (approximately 20%) also respond strongly to stimulator cells from strains expressing stimulatory alleles at the chromosome 1-encoded Mls-locus. Furthermore, such responses are blocked by monoclonal antibodies specific for Ia antigens expressed by the stimulator rather than the responder cells. However, such responses show no specificity for polymorphic determinants on Ia molecules, although in such responses, as in primary and secondary T cell responses to stimulating Mls-locus alleles, I-E molecules appear to play a central role. These results, combined with the unique immunobiology of the primary T cell proliferative response to Mls-locus-disparate stimulator cells, suggest to us that this response involves the interaction of the receptor on T cells for antigen:self Ia with a relatively nonpolymorphic region of Ia glycoproteins. This hypothesis is supported by the observation that a monoclonal antibody to the T cell receptor will inhibit both responses, although the response to Mls-locus-disparate stimulators appears to be more sensitive to these antibodies. We propose that the interaction of the T cell receptor with Ia is stabilized by a cell interaction molecule encoded or regulated by the Mls-locus gene product permitting the T cell receptor:Ia glycoprotein interaction to lead to T cell activation.

Mesh:

Substances:

Year:  1985        PMID: 2579126

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  11 in total

1.  Differential induction of interferon gamma gene expression after activation of CD4+ T cells by conventional antigen and Mls superantigen.

Authors:  R Patarca; F Y Wei; M V Iregui; H Cantor
Journal:  Proc Natl Acad Sci U S A       Date:  1991-04-01       Impact factor: 11.205

2.  Allogeneic substitution for nominal antigen-specific T-cell clone reactivity in schistosomiasis.

Authors:  G P Linette; P J Lammie; S M Phillips
Journal:  Immunology       Date:  1986-04       Impact factor: 7.397

3.  The expression of Mlsc determinants on Mlsa, Mlsb, and Mlsx prototypic strains.

Authors:  R Abe; R J Hodes
Journal:  Immunogenetics       Date:  1988       Impact factor: 2.846

4.  The J alpha segment contributes to the affinity of V beta 6+ cells for vSAG-7 (Mls-1a) presented by I-A molecules.

Authors:  E Churaqui; M Oukka; F Tilloy; E Mayadoux; M Bruley-Rosset; K Kosmatopoulos
Journal:  Immunology       Date:  1995-04       Impact factor: 7.397

5.  H-2-linked genes determine the level of the primary in vitro anti-Mls response.

Authors:  S Macphail; O Stutman
Journal:  Immunogenetics       Date:  1986       Impact factor: 2.846

6.  T cell receptor-major histocompatibility complex class II interaction is required for the T cell response to bacterial superantigens.

Authors:  N Labrecque; J Thibodeau; W Mourad; R P Sékaly
Journal:  J Exp Med       Date:  1994-11-01       Impact factor: 14.307

7.  Paracrine transfer of mouse mammary tumor virus superantigen.

Authors:  M Delcourt; J Thibodeau; F Denis; R P Sekaly
Journal:  J Exp Med       Date:  1997-02-03       Impact factor: 14.307

8.  Downregulation of T cell responses by antibodies to the T cell receptor.

Authors:  S Webb; J Sprent
Journal:  J Exp Med       Date:  1987-02-01       Impact factor: 14.307

9.  Restricted tissue distribution of Mlsa determinants. Stimulation of Mlsa-reactive T cells by B cells but not by dendritic cells or macrophages.

Authors:  S R Webb; A Okamoto; Y Ron; J Sprent
Journal:  J Exp Med       Date:  1989-01-01       Impact factor: 14.307

10.  Direct interactions between B and T lymphocytes bearing complementary receptors.

Authors:  J P Tite; J Kaye; K M Saizawa; J Ming; M E Katz; L A Smith; C A Janeway
Journal:  J Exp Med       Date:  1986-01-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.